BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy

Please take some time to read this important press release regarding a Phase 1 Clinical Study of Duchenne muscular dystrophy.

BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy

*

*

Related posts:

1. Acceleron Pharma`s ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial Please take some time to read this important report: Acceleron...
2. Prosensa and GlaxoSmithKline Form Alliance to Fight Duchenne Muscular Dystrophy CureDuchenne is very pleased to forward this announcement from Prosensa. ...
3. Diagnosis and Management of Duchenne Muscular Dystrophy Please take some time to read this important document regarding...
4. Mothers Luncheon Discusses Duchenne Muscular Dystrophy Yesterday, a group of 15 women from the LA/Orange County...

Related posts brought to you by Yet Another Related Posts Plugin.